MISSION/HISTORY
  DIRECTOR
  Sylvain Bourgoin     
 
  RESEARCHERS
  Fawzi Aoudjit          
  Pierre Borgeat        
  Maria Fernandes     
  Louis Flamand         
  François Marceau          
  Paul Naccache     
  Patrice Poubelle      
  Marc Pouliot            
  Patrick Provost        
  Raynald Roy            
  Jean Sévigny           
 
  SCIENTIFIC MEETINGS
  PERSONNEL/BUDGET
  VIRTUAL VISIT
  ALUMNI
Any questions?

Webmaster

François MARCEAU, MD, PhD
Professor, Department of Medicine, Faculty of Medicine, Université Laval.


Centre de Recherche en
Rhumatologie et Immunologie
2705, Boulevard Laurier, local T1-49
Quebec, QC
G1V 4G2 Canada
Tel: 418-656-4141 ext. 46155 (office)
Tel: 418-656-4141 ext. 46102 (laboratory)
Fax: 418-654-2765
E-mail:
Francois.Marceau@crchul.ulaval.ca

Research Themes | Research Projects | Selected References | List of Publications | Research Personnel | Additional Information

Research Themes
 

Peptide mediators of inflammation : the kallikrein-kinin system and the receptors for bradykinin-related peptides
Ion trapping of basic drugs into acidic cell compartments : consequences for the safety and efficacy of drugs from multiple therapeutic classes
Chronic inflammatory processes at work in tumor biology

Top of page

 
Research Projects
  >> CARDIOVASCULAR PHARMACOLOGY OF THE B1 AND B2 RECEPTORS FOR KININS  

The kinins (bradykinin-related peptides) are blood-derived mediators that act on endothelial cells (producing endothelium-dependent vasodilation, increased vascular permeability), but also on smooth muscle cells, afferent sensory neurons (inflammatory pain) and other tissues. I have maintained a career-long interest in the pharmacology of kinins, initially with studies on the mechanism of the induction of the B1 receptor subtype in immunopathology and, subsequently, on the agonist-induced translocation/cycling of both B1 and B2 receptors, the characterization of novel ligands (now close to clinical evaluation) and the relationship between receptors and other critical physiopathological processes (interaction with proteases/peptidases, the tissue factor-induced initiation of coagulation and other reactions relevant to sepsis and vascular biology).

This project is supported by the Canadian Institutes of Health Research (CIHR).

Top of page

 
>> ION TRAPPING AND VACUOLIZATION : CONSEQUENCES FOR THE SAFETY AND EFFICACY OF BASIC DRUGS  
  Many clinically used drugs are basic amines (pKa 6 to 10) that are concentrated in acidic cell compartments, especially the trans-Golgi and other organelles that possess the V-ATPase. The drugs, representing many different therapeutic classes, remain trapped for prolonged periods. This form of reservoir formation is generally counterproductive as it alters the drug pharmacokinetics, distribution and concentration at the sites of action. Further, it is suspected that concentrated amines applied locally or into confined anatomical areas will osmotically attract water when sufficiently accumulated, producing massive cell vacuolization, stress signaling and inflammatory reactions (such as rhinitis medicamentosa, the side effect of nasal decongestants applied to the mucosa). The project aim to identify the cell organelles affected by such trapping, its molecular mechanisms and cellular consequences and to measure its effect on the duration of action and dose-response relationship for a model drug class, the adrenoceptor agonists.

This project is supported by the Canadian Institutes of Health Research (CIHR).

Top of page

 
>> INFLAMMATORY GENES AS VIRULENCE FACTORS IN TUMORIGENIC CELL LINES  
  Several inflammatory genes may act as progression factors in solid tumors, at least in part because they promote angiogenesis: tissue factor, the bradykinin B1 receptor, inducible nitric oxide synthase (iNOS) and COX2. The following questions will be pursued: What is the effect of expressed transgenes selected from the list mentioned above (tissue factor, kinin receptors) on the biology of tumorigenic cell lines? (migration, MAP kinase stimulation, cell growth, effect of ligands of these surface proteins). What is the effect of these transgenes on the tumors formed in the chorioallantoic membrane? (vascular density and configuration, tumor growth, effect of drug co-administration).

This project is supported by The Cancer Research Society, Inc.

Top of page

 
Selected references  
 

Houle S., and Marceau F. (2003) Wortmannin alters intracellular trafficking of the bradykinin B2 receptor: role of phosphatidylinositol-3 kinase and Rab5. Biochem. J. 375: 151-158. PubMed Link

Fortin J.P., Rivard G.E., Adam A., and Marceau F. (2005) Studies on rabbit natural and recombinant tissue factors: intracellular retention and regulation of surface expression in cultured cells. Am. J. Physiol. Heart Circ. Physiol. 288: H2192-2202. PubMed Link

Fortin J.P., Dziadulewicz E.K., Gera L., and Marceau F. (2006) A nonpeptide antagonist reveals a highly glycosylated state of the rabbit kinin B 1 receptor. Mol. Pharmacol. 69: 1146-1157. PubMed Link

Morissette G., Petitclerc E., and Marceau F. (2004) Loss of function of vascular smooth muscle cells by nitric oxide-dependent and -independent interactions with tumorigenic cells. Int. J. Cancer 112 : 830-839. PubMed Link

Morissette G., Moreau E., C.-Gaudreault R., and Marceau F. (2005) N -substituted 4-aminobenzamides (procainamide analogs) : an assessment of multiple cellular effects concerning ion trapping. Mol. Pharmacol. 68: 1576-1589. PubMed Link

Top of page

 

List of Publications - PubMed Link

Top of page

 
Research Personnel      
  Research Assistant   Graduate Students
  Johanne Bouthillier, DEC

 

Jean-Philippe Fortin, MSc
Guillaume Morissette, MSc
Marie-Thérèse Bawolak, BSc

Top of page

Additional Information Details